Screening recommendations issued by the USPSTF in the past year will be summarized and reviewed. The most significant and controversial topics will be prioritized. Within the past year, the USPSTF has issued screening recommendation statements on the following topics: cervical, prostate, and ovarian cancer; osteoporosis; CVD; atrial fibrillation; syphilis among pregnant women; adolescent idiopathic scoliosis; and vision problems among young children.
Guidelines for immunizations and cancer screening recommendations are constantly in flux as new data emerges. This session will review some current recommendations for vaccinations and cancer screening in children and adults in addition to controversies related to these recommendations.
This activity will review the current recommendations for screening (and the evidence behind them) for women-specific cancers. Dr. Friedman from the David Geffen School of medicine at UCLA will discuss up to date recommendations for screening for cervical, breast and ovarian cancers.
In the Unites States, it is estimated that there are 1.2 million persons living with HIV. This program will discuss appropriate screening patients for HIV infection and how to recognize signs and symptoms of acute retroviral syndrome. Treatment will also be discussed along with what factors influence the selection of an antiretroviral regimen and when pre-exposure prophylaxis is indicated.
A primary care physician plays a crucial role in the maintenance of herd immunity by giving and recommending vaccines to their patients. Currently, there exists a gap between national immunization goals and the current rates of immunization. This activity reviews the latest ACIP guidelines for vaccinating adult patients, with special emphasis on vaccine recommendations for immunocompromised patients.
In this activity, Daniel Dunham, MD, reviews the pros and cons of screening for cancer, including what characteristics constitute a good screening test. He also discusses screening tests for some common cancer types and the current evidence for or against them.
Screening of the young athlete ranges from questionnaires to advanced cardiovascular diagnostic testing. The risk of disease in this population is quite low, yet each event has devastating consequences to families and communities. Prevention of even one event makes such clear moral sense that we feel obligated to employ any and all available tools that could possibly help do just that. It is important that we understand the tools available and that we use them effectively to save as many susceptible young lives as possible. It will be the goal of this talk to best understand the tools available with their advantages and disadvantages. We will also discuss the controversies surrounding these population health screening programs.
This talk will review the latest epidemiology of the HIV epidemic in New York. The 2015 update of the Department of Health and Human Services guidelines for first-line treatment regimens will be discussed, and a brief update of the latest data on treatment as prevention will be presented. The latest data addressing the advantages of the early initiation of antiretrovirals will also be presented. Finally, Dr. Scherer will discuss pre-exposure prophylaxis, or PrEP, and will provide practical guidance for the provision of PrEP in primary care practice.
In this activity, Lowell Schnipper, the Theodore and Evelyn Berenson Professor of Medicine at Harvard Medical School, uses several brief cases to highlight the appropriate follow-up and surveillance for patients following primary treatment for breast cancer and colorectal cancer.
In this activity, Dr. Dumanian will discuss the pathophysiology and symptoms of carpal tunnel syndrome and provide with the know-how to diagnose this condition in patients. Dr. Dumanian will also outline various treatment options, both surgical and non-surgical for the management of carpal tunnel syndrome.
This presentation will provide an overview of existing trends in addictive disorders with an emphasis on screening, brief interventions and referrals to treatment (SBIRT) practices that every primary care provider should practice. A review of FDA-approved medications and evidence-based psychosocial practices will be presented. Finally, special emphasis will be placed on describing office-based tools that can be used to identify and prevent prescription opiate abuse.
Dr. Galluzzi will discuss the best approaches for screening seniors and the elderly for cancers and other diseases. She will explain the cost-benefit analyses a physician should employ before ordering screening tests in their geriatric patient population and discuss generating a practical strategy for determining the stopping age for cancer screening.